AIxCrypto to Acquire $10 Million Stake in Faraday Future
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 06 2026
0mins
Source: Newsfilter
- Strategic Investment: AIxCrypto has entered a non-binding term sheet to acquire $10 million in common stock from Faraday Future, marking a significant strategic deployment of AIxC's blockchain infrastructure and advancing its tokenized Real World Asset business.
- Asset Digitization: This initiative aims to leverage AIxC's blockchain technology to digitize the equity issuance lifecycle, creating a digital bridge between traditional capital markets and the on-chain economy, which will enhance operational efficiencies and expand access for a global digital-native investor base.
- Liquidity and Compliance: AIxC intends to utilize the liquidity and programmability of blockchain technology while adhering to strict governance standards, ensuring that the foundational assets for its tokenized equity products maintain high liquidity and competitive market positioning.
- Future Updates: Should definitive agreements be executed, AIxC will provide further updates, demonstrating the company's agility in the rapidly evolving blockchain market and its commitment to future growth opportunities.
Analyst Views on AIXC
About AIXC
AIxCrypto Holdings, Inc., formerly Qualigen Therapeutics, Inc., is focused on building an ecosystem that integrates Artificial Intelligence (AI) and blockchain, bridging Web2 and Web3. This ecosystem unites a decentralized protocol, distributed network, AI DePIN and EAI RWA value regeneration, and a DeAI Agent product and technology platform designed to achieve optimal trading performance. Its core products include the BesTrade DeAI Agent and the AIxC ecosystem products. Its crypto business, CXC10, is centered on three growth engines which include six key products: C - Crypto 10 (C10) as Value Anchor, X - DeAI Agent, and C - RWA & Ecosystem Tokens. C - Crypto 10 (C10) as Value Anchor - through the C10 Digital Asset Treasury, C10 Index, and a potential C10 ETF. C - RWA & Ecosystem Tokens - including the C10 Stablecoin and the EAI + Crypto Dual-Bridge Real World Asset product, bridging traditional assets with Web3. It also develops and commercializes oncology and immunology therapies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
